Zivo Bioscience Inc (NASDAQ:ZIVO) — Market Cap & Net Worth
Market Cap & Net Worth: Zivo Bioscience Inc (ZIVO)
Zivo Bioscience Inc (NASDAQ:ZIVO) has a market capitalization of $16.61 Million ($16.61 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25641 globally and #5336 in its home market, demonstrating a -16.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zivo Bioscience Inc's stock price $4.00 by its total outstanding shares 4151607 (4.15 Million). Review ZIVO free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
Zivo Bioscience Inc Market Cap History: 2015 to 2026
Zivo Bioscience Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.43 Million to $16.61 Million (21.94% CAGR).
Zivo Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zivo Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
348.80x
Zivo Bioscience Inc's market cap is 348.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $4.11 Million | $20.00K | -$14.67 Million | 205.50x | N/A |
| 2020 | $3.74 Million | $20.00K | -$9.66 Million | 186.82x | N/A |
| 2022 | $62.27 Million | $4.05K | -$8.75 Million | 15376.32x | N/A |
| 2023 | $4.98 Million | $27.65K | -$7.78 Million | 180.18x | N/A |
| 2024 | $86.73 Million | $157.22K | -$13.38 Million | 551.63x | N/A |
| 2025 | $41.52 Million | $119.03K | -$9.89 Million | 348.80x | N/A |
Competitor Companies of ZIVO by Market Capitalization
Companies near Zivo Bioscience Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Zivo Bioscience Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Zivo Bioscience Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Zivo Bioscience Inc's market cap moved from $1.43 Million to $ 16.61 Million, with a yearly change of 21.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $16.61 Million | -60.00% |
| 2025 | $41.52 Million | -52.13% |
| 2024 | $86.73 Million | +1640.83% |
| 2023 | $4.98 Million | -92.00% |
| 2022 | $62.27 Million | -12.89% |
| 2021 | $71.49 Million | +1813.33% |
| 2020 | $3.74 Million | -9.09% |
| 2019 | $4.11 Million | +26.92% |
| 2018 | $3.24 Million | +37.42% |
| 2017 | $2.36 Million | -0.42% |
| 2016 | $2.37 Million | +65.22% |
| 2015 | $1.43 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Zivo Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.61 Million USD |
| MoneyControl | $16.61 Million USD |
| MarketWatch | $16.61 Million USD |
| marketcap.company | $16.61 Million USD |
| Reuters | $16.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zivo Bioscience Inc
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically act… Read more